Nutrient-stimulated glucagon-like peptide 1 release after body-weight loss and weight maintenance in human subjects

British Journal of Nutrition

Volumn 95, Issue 1, 2006, Pages 160-167

  Adam, Tanja C M ^a   Lejeune, Manuela P G M ^a   Westerterp Plantenga, Margriet S ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Appetite; Glucagon like peptide 1; Obesity; Very low energy diets; Weight loss; Weight maintenance

Indexed keywords

FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; ENERGY BALANCE; GLUCOSE BLOOD LEVEL; HUMAN; INGESTION; INSULIN BLOOD LEVEL; MEAL; NUTRIENT; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; STIMULATION; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; APPETITE; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIET; ENERGY INTAKE; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 32844461382     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20051614     Document Type: Article

References (42)

1. Bennink R, Peelers M, van den Maegdenbergh V, Geypens B, Rutgeerts P, De Roo M & Mortelmans L (1999) Evaluation of small-bowel transit for solid and liquid test meals in healthy men and women. Eur J Nucl Med 26, 1560-1566.
2. Blundell JE, Lawton CL & Hill AJ (1993) Mechanisms of appetite control and their abnormalities in obese patients. Horm Res 39, 72-76.
3. Blundell JE & Näslund E (1999) Glucagon-like peptide-1, satiety and appetite control. Br J Nutr 81, 259-260.
4. Cigaina V & Hirschberg AL (2003) Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 11, 1456-1462.
5. Clark MM, Marcus BH, Pera V & Niaura RS (1994) Changes in eating inventory scores following obesity treatment. Int J Eat Disord 15, 401-405.
6. Flint A, Raben A, Astrup A & Holst JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101, 515-520.
7. Flint A, Raben A, Ersboll AK, Holst JJ & Astrup A (2001) The effect of physiological levels of glucagon-like peptide 1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25, 781-792.
8. Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M & Sasaki H (1993) Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med 10, 44-49.
9. Hansen L, Hartmann B, Mineo H & Holst JJ (2004) Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum. Regul Pept 118, 11-18.
10. Herrmann C, Göke R, Richter G, Fehmann HC, Arnold R & Göke B (1995) Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56, 117-126.
11. Holst JJ (1994) Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 107, 1848-1855.
12. Kanauchi M, Yamano S, Kanauchi K & Saito Y (2003) Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 88, 3444-3446.
13. Kovacs EM, Lejeune MP, Nijs I & Westerterp-Plantenga MS (2004) Effects of green tea on weight maintenance after body-weight loss. Br J Nutr 91, 431-437.
14. Lejeune MP, Kovacs EM & Westerterp-Plantenga MS (2003a) Effect of capsaicin on substrate oxidation and weight maintenance after modest body-weight loss in human subjects. Br J Nutr 90, 651-659.
15. Lejeune MP, van Aggel-Leijssen DP, van Baak MA & Westerterp-Plantenga MS (2003b) Effects of dietary restraint vs exercise during weight maintenance in obese men. Eur J Clin Nutr 57, 1338-1344.
16. Lugari R, Dei Cas A, Ugolotti D et al. (2004) Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. Horm Metab Res 36, 111-115.
17. Murphy KG & Bloom SR (2004) Gut hormones in the control of appetite. Exp Physiol 89, 507-516.
18. Näslund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, Rössner S & Hellström PM (1999a) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 23, 304-311.
19. Näslund E, Bogefors J, Skogar S, Gryback P, Jacobsson H, Holst JJ & Hellström PM (1999b) GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. Am J Physiol 277, R910-R916.
20. Nathan DM, Schreiber E, Fogel H, Mojsov S & Habener JF (1992) Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 15, 270-276.
21. Pasman WJ, Saris WH, Muls E, Vansant G & Westerterp-Plantenga MS (1999) Effect of exercise training on long-term weight maintenance in weight-reduced men. Metabolism 48, 15-21.
22. Pekkarinen T, Takala I & Mustajoki P (1996) Two year maintenance of weight loss after a VLCD and behavioural therapy for obesity: correlation to the scores of questionnaires measuring eating behaviour. Int J Obes Relat Metab Disord 20, 332-337.
23. Peronnet F & Massicotte D (1991) Table of nonprotein respiratory quotient: an update. Can J Sport Sci 16, 23-29.
24. Plasqui G, Kester AD & Westerterp KR (2003) Seasonal variation in sleeping metabolic rate, thyroid activity, and leptin. Am J Physiol 285, E338-E343.
25. Ranganath L, Norris F, Morgan L, Wright J & Marks V (1999) Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36) amide secretion by circulating non-esterified fatty acids. Clin Sci (Lond) 96, 335-342.
26. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R & Marks V (1996) Attenuated GLP-1 secretion in obesity: cause or consequence?" Gut 38, 916-919.
27. Ravussin E & Bogardus C (1989) Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 49, 968-975.
28. Schoeller DA, van Santen E, Peterson DW, Dietz W, Jaspan J & Klein PD (1980) Total body water measurement in humans with 18O and 2H labeled water. Am J Clin Nutr 33, 2686-2693.
29. Schoffelen PF, Westerterp KR, Saris WH & Ten Hoor F (1997) A dual-respiration chamber system with automated calibration. J Appl Physiol 83, 2064-2072.
30. Siri WE (1956) The gross composition of the body. Adv Biol Med Physiol 4, 239-280.
31. Stunkard AJ & Messick S (1985) The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 29, 71-83.
32. van Gaal LF, Wauters MA & De Leeuw IH (1997) The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord 21, Suppl. 1, S5-S9.
33. van Marken Lichtenbelt WD, Westerterp KR & Wouters L (1994) Deuterium dilution as a method for determining total body water: effect of test protocol and sampling time. Br J Nutr 72, 491-497.
34. Verdich C, Flint A, Gutzwiller J-P, Näslund E, Beglinger C, Hellstroem PM, Long SJ, Morgan LM, Holst JJ & Astrup A (2001a) A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86, 4382-4389.
35. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J & Astrup A (2001b) The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25, 1206-1214.
36. Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG & Holst JJ (2003) Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88, 2706-2713.
37. Weir JB (1949) New methods for calculating metabolic rate with special reference to protein metabolism. Nutrition 6, 213-221.
38. Westerterp-Plantenga MS, Kempen KP & Saris WH (1998) Determinants of weight maintenance in women after diet-induced weight reduction. Int J Obes Relat Metab Disord 22, 1-6.
39. Westerterp-Plantenga MS, Lejeune MP, Nijs I, van Ooijen M & Kovacs EM (2004) High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord 28, 57-64.
40. Westerterp-Plantenga MS, Rolland V, Wilson SA & Westerterp KR (1999) Satiety related to 24 h diet-induced thermogenesis during high protein/carbohydrate vs high fat diets measured in a respiration chamber. Eur J Clin Nutr 53, 495-502.
41. Wisen O & Johansson C (1992) Gastrointestinal function in obesity: motility, secretion, and absorption following a liquid test meal. Metabolism 41, 390-395.
42. World Health Organization (1998) Obesity: Preventing and Managing the Global Epidemic. Geneva: WHO.